Ralph Smalling - 16 Dec 2024 Form 4 Insider Report for GENELUX Corp (GNLX)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
18 Dec 2024, 16:35:09 UTC
Prior SEC filing
07 Jun 2024
Next SEC filing
20 Dec 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Sean Ryder, Attorney-in-Fact

Key filing fact

Ralph Smalling filed Form 4 for GENELUX Corp (GNLX) on 18 Dec 2024.

Key facts

  • This page summarizes Ralph Smalling's Form 4 filing for GENELUX Corp (GNLX).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 18 Dec 2024, 16:35.

Change

  • Previous filing in this sequence was filed on 07 Jun 2024.
  • Current net transaction value: -$5,873.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

GNLX transaction

Common Stock

Sale

Transaction value
$5,873
Shares
-2,510
Change %
-13%
Price
$2.34
Shares after
16,322
Date
16 Dec 2024
Ownership
Direct
Footnotes
F1, F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents shares sold by the Reporting Person to cover estimated taxes to be paid by the Reporting Person in connection with the vesting of restricted stock units.

Footnote F2

Includes 688 shares acquired under the Issuer's Employee Stock Purchase Plan on November 15, 2024.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .